GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » Change In Working Capital
中文

Movano (Movano) Change In Working Capital : $-0.27 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Movano Change In Working Capital?

Movano's change in working capital for the quarter that ended in Dec. 2023 was $-0.29 Mil.

Movano's change in working capital for the fiscal year that ended in Dec. 2023 was $-0.27 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


Movano Change In Working Capital Historical Data

The historical data trend for Movano's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Movano Change In Working Capital Chart

Movano Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Working Capital
Get a 7-Day Free Trial 0.12 -0.73 1.34 2.05 -0.27

Movano Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.26 -1.43 1.19 -0.29

Movano Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Movano Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Movano's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Movano (Movano) Business Description

Traded in Other Exchanges
N/A
Address
6800 Koll Center Parkway, Pleasanton, CA, USA, 94566
Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.
Executives
Jeremy Cogan officer: CFO 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman director, officer: CEO and President 207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn director 10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro director 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan officer: CFO 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte director 111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero director C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust 10 percent owner 6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin 10 percent owner 303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc 10 percent owner 401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho 10 percent owner C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016